134 related articles for article (PubMed ID: 26718643)
1. Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris.
Su M; Chang W; Zhang K; Cui M; Wu S; Xu T
Oncol Rep; 2016 Feb; 35(2):1179-85. PubMed ID: 26718643
[TBL] [Abstract][Full Text] [Related]
2. Expression and anticancer activity analysis of recombinant human uPA1‑43-melittin.
Su M; Chang W; Cui M; Lin Y; Wu S; Xu T
Int J Oncol; 2015 Feb; 46(2):619-26. PubMed ID: 25394558
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.
Su M; Chang W; Wang D; Cui M; Lin Y; Wu S; Xu T
Oncol Rep; 2015 Sep; 34(3):1337-44. PubMed ID: 26166362
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional characterization of a recombinant targeted toxin with an uPA cleavable linker in Pichia pastoris.
Zhu Wh; Sun Mn; Wang Ys; Sun DJ; Zhang Sx
Protein Expr Purif; 2011 Apr; 76(2):184-9. PubMed ID: 21144903
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and biological characterization of the amino-terminal fragment of urokinase in Pichia pastoris.
Li J; Lin Y; Zhuang H; Hua ZC
J Microbiol Biotechnol; 2013 Sep; 23(9):1197-205. PubMed ID: 23751561
[TBL] [Abstract][Full Text] [Related]
6. High-level expression, purification and study of bioactivity of fusion protein M-IL-2((88)Arg, (125)Ala) in Pichia pastoris.
Li L; Qian D; Shao G; Yan Z; Li R; Hua X; Song X; Wang B
Protein Expr Purif; 2014 Sep; 101():99-105. PubMed ID: 24955549
[TBL] [Abstract][Full Text] [Related]
7. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.
Liu X; Liu X; Sunchen S; Liu M; Shen C; Wu J; Zhao W; Yu B; Liu J
Drug Deliv; 2017 Nov; 24(1):1811-1817. PubMed ID: 29172777
[TBL] [Abstract][Full Text] [Related]
8. [Expression and antitumor activity of fusion protein RGD-TRAIL in Pichia pastoris].
Wang XF; Chen SZ
Yao Xue Xue Bao; 2015 May; 50(5):552-9. PubMed ID: 26234135
[TBL] [Abstract][Full Text] [Related]
9. Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.
Errico Provenzano A; Posteri R; Giansanti F; Angelucci F; Flavell SU; Flavell DJ; Fabbrini MS; Porro D; Ippoliti R; Ceriotti A; Branduardi P; Vago R
Microb Cell Fact; 2016 Nov; 15(1):194. PubMed ID: 27842546
[TBL] [Abstract][Full Text] [Related]
10. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
Zuppone S; Assalini C; Minici C; Bertagnoli S; Branduardi P; Degano M; Fabbrini MS; Montorsi F; Salonia A; Vago R
Sci Rep; 2020 Feb; 10(1):2521. PubMed ID: 32054892
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, and characterization of recombinant human neurturin secreted from the yeast Pichia pastoris.
Li H; Ma Y; Su T; Che Y; Dai C; Sun M
Protein Expr Purif; 2003 Jul; 30(1):11-7. PubMed ID: 12821316
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro.
Takei Y; Mizukami H; Saga Y; Kobayashi H; Suzuki M; Matsushita T; Ozawa K; Suzuki M
Int J Cancer; 2005 Jan; 113(1):54-8. PubMed ID: 15386422
[TBL] [Abstract][Full Text] [Related]
15. Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.
Xiang Y; Li Q; Huang D; Tang X; Wang L; Shi Y; Zhang W; Yang T; Xiao C; Wang J
Exp Biol Med (Maywood); 2015 Feb; 240(2):160-8. PubMed ID: 25125500
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.
Zhang Y; Kenny HA; Swindell EP; Mitra AK; Hankins PL; Ahn RW; Gwin K; Mazar AP; O'Halloran TV; Lengyel E
Mol Cancer Ther; 2013 Dec; 12(12):2628-39. PubMed ID: 24061648
[TBL] [Abstract][Full Text] [Related]
18. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
19. [Expression of recombinant human zona pellucida-3 protein (rhZP3) in Pichia pastoris].
Tang J; Xie QX; Pan SP; Xiao LJ; Dong L; Zhang CX; Sun CJ
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):758-62. PubMed ID: 15971594
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris.
Wang DD; Su MM; Sun Y; Huang SL; Wang J; Yan WQ
Protein Expr Purif; 2012 Nov; 86(1):75-81. PubMed ID: 22982755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
